Nilotinib Induces Autophagy in Hepatocellular Carcinoma through AMPK Activation
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nilotinib Induces Autophagy in Hepatocellular Carcinoma through AMPK Activation
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 288, Issue 25, Pages 18249-18259
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2013-05-16
DOI
10.1074/jbc.m112.446385
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Autophagy in tumorigenesis and cancer therapy: Dr. Jekyll or Mr. Hyde?
- (2012) Shengtao Zhou et al. CANCER LETTERS
- PP2A blockade inhibits autophagy and causes intraneuronal accumulation of ubiquitinated proteins
- (2012) Amandine Magnaudeix et al. NEUROBIOLOGY OF AGING
- Kinematic and dynamic gait compensations resulting from knee instability in a rat model of osteoarthritis
- (2012) Kyle D Allen et al. ARTHRITIS RESEARCH & THERAPY
- Patterns of Care, Prognosis, and Survival in Patients with Metastatic Gastrointestinal Stromal Tumors (GIST) Refractory to First-Line Imatinib and Second-Line Sunitinib
- (2011) Antoine Italiano et al. ANNALS OF SURGICAL ONCOLOGY
- Evaluation of nilotinib in advanced GIST previously treated with imatinib and sunitinib
- (2011) C. Cauchi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Pancreatic cancers require autophagy for tumor growth
- (2011) S. Yang et al. GENES & DEVELOPMENT
- Release of intracellular calcium primes chronic myeloid leukaemia cells for tyrosine kinase inhibitor-induced apoptosis
- (2011) S L Forchap et al. LEUKEMIA
- Bortezomib Sensitizes HCC Cells to CS-1008, an Antihuman Death Receptor 5 Antibody, through the Inhibition of CIP2A
- (2011) K.-F. Chen et al. MOLECULAR CANCER THERAPEUTICS
- The Structural Basis for Tight Control of PP2A Methylation and Function by LCMT-1
- (2011) Vitali Stanevich et al. MOLECULAR CELL
- c-Abl and Arg are activated in human primary melanomas, promote melanoma cell invasion via distinct pathways and drive metastatic progression
- (2011) S S Ganguly et al. ONCOGENE
- Inhibitory effect of ethanol on AMPK phosphorylation is mediated in part through elevated ceramide levels
- (2010) Suthat Liangpunsakul et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells
- (2010) K-F Chen et al. ONCOGENE
- PP2A Mediated AMPK Inhibition Promotes HSP70 Expression in Heat Shock Response
- (2010) Ting Wang et al. PLoS One
- Regulation Mechanisms and Signaling Pathways of Autophagy
- (2009) Congcong He et al. Annual Review of Genetics
- Extended kinase profile and properties of the protein kinase inhibitor nilotinib
- (2009) Paul W. Manley et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Short-term intense Bcr–Abl kinase inhibition with nilotinib is adequate to trigger cell death in BCR-ABL+ cells
- (2009) D K Hiwase et al. LEUKEMIA
- Discovery of Atg5/Atg7-independent alternative macroautophagy
- (2009) Yuya Nishida et al. NATURE
- Structure of the LKB1-STRAD-MO25 Complex Reveals an Allosteric Mechanism of Kinase Activation
- (2009) E. Zeqiraj et al. SCIENCE
- OSU-03012, a Novel Celecoxib Derivative, Induces Reactive Oxygen Species-Related Autophagy in Hepatocellular Carcinoma
- (2008) M. Gao et al. CANCER RESEARCH
- Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies
- (2008) S Sarkar et al. CELL DEATH AND DIFFERENTIATION
- Nilotinib: a phenylamino-pyrimidine derivative with activity against BCR-ABL, KIT and PDGFR kinases
- (2008) Alfonso Quintás-Cardama et al. Future Oncology
- Frameshift mutations of autophagy-related genesATG2B, ATG5, ATG9BandATG12in gastric and colorectal cancers with microsatellite instability
- (2008) Mi Ran Kang et al. JOURNAL OF PATHOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now